Please provide your email address to receive an email when new articles are posted on . Despite significantly extending survival for younger adults with advanced non-small cell lung cancer, immune ...
Obesity and age do not appear to influence the survival of patients with non-small cell lung cancer (NSCLC) treated with programmed death receptor-1 (PD-1)/programmed cell death ligand 1 (PD-L1) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback